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Background: Diabetes is now becoming a major cause of morbidity and mortality in both developing and developed
countries. Even though type 1 and type 2 are the commonest, diabetes mellitus due to secondary causes have
been identified. Fibrocalculous Pancreatic Diabetes is a unique entity wherein pancreatic calcification and chronic
inflammation lead to exocrine and endocrine failure of the pancreas. This form of non-alcoholic pancreatopathy
is exclusively seen among the young, with a male preponderance and commonly in tropical countries where
malnutrition and poverty go hand in hand. Whereas, interestingly this case has a late presentation in a female,
unlike in other reported cases. For the best of our knowledge this is the first such documented case reported in
Sri Lanka.
Case presentation: A 57 year old non-alcoholic Sinhalese female from Sri Lanka, presented with a history of
chronic pancreatitis of nine years duration, after which she had developed severe Insulin Dependent Diabetes
Mellitus. Imaging of the abdomen showed typical pancreatic calcifications, and this presentation accords with the
criteria for Fibrocalculous pancreatic diabetes.
Conclusion: This case report demonstrates a rare form of secondary diabetes in a middle aged female, without a
childhood history of abdominal pain suggestive of pancreatitis, indicating late onset disease. Therefore a high
index of suspicion is necessary even though the diagnostic criteria indicates the presence of childhood onset of
disease.
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Fibrocalculous pancreatic diabetes mellitus (FCDP) is a
unique form of diabetes mellitus, which is secondary to
chronic calcification of the pancreas in young non-
alcoholic people and exclusively found in tropical coun-
tries [1]. The hall-marks of the disease are the occurrence
of abdominal pain since childhood and pancreatic calculi
associated with dilatation of the pancreatic duct and fibro-
sis of the gland in adolescence [2]. Various terminologies
have been proposed for this form of diabetes, including
Pancreatic Diabetes, Pancreatogenous Diabetes, and Trop-
ical Pancreatic Diabetes. Recently the term Fibrocalculus
Pancreatic Diabetes was introduced for this form of dia-
betes by the World Health Organization (WHO) Study
Group Report on Diabetes [2,3].* Correspondence: udayapralapanawa@yahoo.com
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unless otherwise stated.There is only one reported population based study on
the prevalence of tropical chronic pancreatitis. Balaji
made a systematic survey of 6079 families of a district
in Kerala. A population of 28,507 was studied and 1 in
1020 subjects had Chronic calcific pancreatitis (0.09%) [4].
Case presentation
A 57 year old previously well Sinhalese Sri Lankan fe-
male who was referred to the Diabetic clinic in a Teach-
ing Hospital, had a past history of intermittent epigastric
discomfort for the past nine years which was initially at-
tributed to and treated for upper gastrointestinal symp-
toms. The abdominal pain was intermittent, burning in
nature and radiated to the back, associated with steator-
rhea and subjective weight loss. She had no past history
of consumption of alcohol or cassava, gall stone disease
or hepatitis, and no family history of pancreatic disease
or diabetes mellitus.
Her initial blood sugar values were in normal range,
but on routine follow up she was detected with poorntral. This is an Open Access article distributed under the terms of the Creative
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level of 128mgdl-1 and HbA1c of 14.6% and, was started
on oral hypoglycemics. Later she was changed on to bi-
phasic insulin four years ago due to poor glycemic con-
trol, and her current insulin regimen is 10U mane and
5U vesper. Interestingly she does not have a history of
clinical presentation similar to ketoacidiosis even with
poor glycemic control. She has no osmotic symptoms,
and no clinical evidence of macrovascular or micro-
vascular complications of diabetes, though she has not
had any nephrology or ophthalmology referral so far.
Until now she was managed for chronic pancreatitis
medically by 30,000 IU of pancreatic enzyme supple-
ments daily, along with other micronutrients, and surgi-
cally by annual Endoscopic Retrograde Cholangio
Pancreatography (ERCP) and stenting for which she has
a good response to pain.
On examination she was emaciated, with a Body Mass
Index (BMI) of 18.1kgm-2, mildly pale, not icteric, no
peripheral stigmata of chronic liver disease, and no fea-
tures of hemochromatosis.
On X-ray abdomen the pancreas was diffusely calcified,
involving the head, body and tail, and changes similar to
chronic pancreatitis [Figures 1 and 2]. Ultrasonography
(USS) and Computed Tomography (CT) scanning of theFigure 1 X-ray abdomen showing generalized pancreatic calcification
involving head, body and tail of the pancreas, more significantly to the
right of the twelfth thoracic and first lumbar vertebrae.abdomen showed pancreatic atrophy and the typical “Bag
of stones” appearance.
Full Blood count revealed hypochromic microcytic an-
aemia with a Haemoglobin of 11.5 g/dl, and iron defi-
ciency anaemia was confirmed by iron studies with a
Transferrin saturation of 13% (20-50%). Alkaline Phos-
phate was marginally elevated (218 IU/l), and serum pro-
tein was low. Thyroid Function tests were normal with a
Thyroid Stimulatimg Hormone (TSH) of 3.53micIU/ml.
Lipid profile showed low levels. Urinalysis showed mar-
ginal microalbuminuria with a urine albumin:creatinine
ratio of 30.39.
Carbohydrate Antigen (CA19-9) was 13U/ml. C-
Peptide level was 0.5 nmol/l (normal 0.5- 1.15). Based
on these findings, the diagnosis of FCDP was made.
Treatment was based on glycaemic control, management
of pain, exocrine and endocrine functions of the pan-
creas. On follow up the patient showed clinical improve-
ment with a BMI of 19.7kgm-2, good glycaemic control,
and is currently free of pain.Discussion
FCPD is a unique form of diabetes mellitus secondary to
pancreatic calcification in non-alcoholics, predominantly
seen in the young [1]. Diagnosis of diabetes mellitus in
FCPD is usually between the ages 10-40, with many hav-
ing a past history of severe epigastric pain characterized
by remissions and exacerbations [5]. Juvenile onset
FCPD has been described in cases reported in Africa
[6,7] and Asia [8,9]. Unlike classical cases, this patient
presented with features of FCPD at the age of 49 years,
which is of late onset, with no childhood history of such.
A previous case report shows two cases of FCPD in eld-
erly which is very rare [10] similar to this case.
The aetio-pathogenesis of FCPD is thought to be multi
factorial, including; malnutrition, toxic effects of cyanide
derived from frequent cassava consumption, familial ag-
gregation; being about 10%, genetic factors; which is
proposed as the main etiology, and increased oxidant
stress from vitamin C and A deficiencies [5]. Current
evidence confirms a link between the serine protease in-
hibitor, Kazal type 1 (SPINK 1) gene and Tropical cal-
cific pancreatitis [11,12]. It is a vital protease inhibitor
that prevents unregulated or inappropriate activation of
the pancreatic enzyme cascade by inhibiting trypsin ac-
tivity [13]. This eventually causes recurrent pancreatitis.
The classical triad of FCPD is abdominal pain, steator-
rhoea, and diabetes and is associated with overt protein
calorie malnutrition. Despite excellent clinical descrip-
tions of the disease, there are no definite criteria for the
diagnosis of FCPD. Mohan et al [14] have proposed the
following criteria for the diagnosis of FCPD, based on
their own studies and extensive review of the literature.
Figure 2 Magnified view of the X-ray abdomen showing generalized pancreatic calcification.
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(Ref. [15])
1. Occurrence in a “tropical” country.
2. Diabetes by WHO Study Group [1] criteria.
3. Evidence of chronic pancreatitis: pancreatic calculi
on X-ray or at least three of the following:
a) Abnormal pancreatic morphology by
ultrasonography
b) Chronic abdominal pain since childhood
c) Steatorrhoea
d) Abnormal pancreatic function test.
4. Absence of other causes of chronic pancreatitis. i.e.
Alcoholism, hepatobiliary disease or primary
hyperparathyroidism etc.
Features like clinical malnutrition, young age at onset
and absence of ketosis are commonly associated fea-
tures, but are not diagnostic criteria by themselves [5].
Though this patient has no chronic abdominal pain
since childhood all other criteria for the diagnosis of
FCPD are fulfilled.
The classic plain radiographic feature of FCPD is the
presence of coarse, well-defined, and dense pancreatic
calcifications [15,16]. The calculi are mostly situated to
the right of the first or second lumbar vertebrae, but
may rarely overlap the spine [5], like in this case. Ultra-
sound scan and CT scans are useful tools in the diagno-
sis of FCPD. CT studies done by Yajnik showed that
pancreatic mass was preserved in early stages with swell-
ing of parenchyma, followed by varying degrees of atro-
phy with progress of disease, and finally being replaced
by the “Bag of stones” appearance in extreme cases [17]
such as in this case.
Malnutrition and low BMI associated with FCPD is
multifactorial. This case reports a significant loss of
weight, with a current BMI of 18.1 kg/m2. A 7 yearfollow-up study done in Pune [18] showed a low BMI in
72% of these Insulin Dependent Diabetes Mellitus (IDDM)
patients implying that diabetes-related malnutrition is a
significant factor, although exocrine pancreatic deficiency
would also add to the problem. In addition, malnutrition
in early life is associated with beta-cell dysfunction and
glucose intolerance in later life [19-21]. Ketosis resist-
ance of these patients, also seen in this case, helps dis-
tinguish them from the usually ketosis-prone IDDM
patients; which is possibly multifactorial in origin [22].
The hypotheseses to explain the ketosis resistance in
Malnutrition related Diabetes are summarized by Yajnik
[17] as:
1. Residual B-cell function adequate to prevent ketosis
2. Concomitant destruction of A-cells and thus loss of
glucagon, a major ketogenic hormone
3. Subcutaneous fat loss and therefore, reduced supply
of Non Esterified fatty acids (NEFA) - the “fuel” for
ketogenesis
4. Resistance of subcutaneous adipose tissue lipolysis to
adrenaline
5. Carnitine deficiency affecting transfer of NEFA
across the mitochondrial membrane
Patients with FCPD usually require insulin though in
small quantities, which is due to the presence of residual
beta cell function reflected by the intermediate C- pep-
tide levels seen in these patients [23].
This case had no macrovascular or microvascular
complications of diabetes mellitus. Long term micro-
vascular complications of FCPD included; Retinopathy
[24] Neuropathy [25], and Nephropathy [26]. In con-
trast, macrovascular complications were less common
[27], perhaps due to the usual young age of onset, their
leanness and the low cholesterol levels [27], but has been
reported in two case reports of FCPD in elderly [10].
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gical interventions if severely intractable and recurrent,
evidenced by this patient having relief of pain following
annual ERCP and stenting. Surgical options include
Drainage procedures, Sphincteroplasty, Pancreatic necro-
sectomy and Celiac plexus ablation. Early surgery has
been found to prevent the development of diabetes in
early stages of the disease [28]. The challenges in man-
agement are recurrent intractable pain, insulin resist-
ance, recurrent hypoglycemia, malnutrition, inability to
adequately correct micro and macronutrient deficiency,
poor drug compliance, misdiagnosis and late diagnosis.
Conclusion
Fibrocalculous Pancreatic Diabetes, though classically
described in the young, can occur in the middle aged,
without a childhood history of abdominal pain, as shown
in this rare case. Therefore a high index of suspicion is
necessary in early diagnosis and treatment. Adequate
glycemic control with regular monitoring, pain relief,
management of macro and micronutrient deficiency and
pancreatic failure are important in improving the quality
of life in patients with FCPD.
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